ACERUS Cash and Equivalents

ASPCF -  USA Stock  

USD 0.02  0.01  33.33%

ACERUS PHARMACEUTICALS CORP fundamentals help investors to digest information that contributes to ACERUS PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of ACERUS OTC Stock. This fundamental analysis module provides a way for investors to measures ACERUS PHARMACEUTICALS's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ACERUS PHARMACEUTICALS otc stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ACERUS Cash and Equivalents 

 
Refresh

ACERUS Cash and Equivalents Analysis

ACERUS PHARMACEUTICALS's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash 
 = 
Bank Deposits 
+  
Liquidities 
More About Cash and Equivalents | All Equity Analysis

Current ACERUS PHARMACEUTICALS Cash and Equivalents

    
  2.27 M  
Most of ACERUS PHARMACEUTICALS's fundamental indicators, such as Cash and Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ACERUS PHARMACEUTICALS CORP is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Compare to competition

In accordance with the recently published financial statements, ACERUS PHARMACEUTICALS CORP has 2.27 M in Cash and Equivalents. This is 99.72% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The cash and equivalents for all United States stocks is 99.92% higher than that of the company.

ACERUS Cash and Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ACERUS PHARMACEUTICALS's direct or indirect competition against its Cash and Equivalents to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of ACERUS PHARMACEUTICALS could also be used in its relative valuation, which is a method of valuing ACERUS PHARMACEUTICALS by comparing valuation metrics of similar companies.
ACERUS PHARMACEUTICALS is currently under evaluation in cash and equivalents category among related companies.

ACERUS Fundamentals

About ACERUS PHARMACEUTICALS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ACERUS PHARMACEUTICALS CORP's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACERUS PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACERUS PHARMACEUTICALS CORP based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ACERUS PHARMACEUTICALS without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Pair Trading with ACERUS PHARMACEUTICALS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACERUS PHARMACEUTICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACERUS PHARMACEUTICALS will appreciate offsetting losses from the drop in the long position's value.

ACERUS PHARMACEUTICALS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for ACERUS PHARMACEUTICALS and Merck Kgaa Dm. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to ACERUS PHARMACEUTICALS Piotroski F Score and ACERUS PHARMACEUTICALS Altman Z Score analysis. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Is ACERUS PHARMACEUTICALS's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACERUS PHARMACEUTICALS. If investors know ACERUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACERUS PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.